Abstract

Abstract The U.S. Food and Drug Administration approved 13 new cancer drugs in 2012, three of them via the accelerated approval process.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call